Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Behav Med. 2019 Jan 3;45(4):294–303. doi: 10.1080/08964289.2018.1534076

Table I:

Clinical and demographic characteristics of persons living with HIV who do and do not skip pills due to aversion symptoms

Skip pills N=94 (25.5) Do not skip pills N=275 (74.5) p-value
Gender <0.001
 Male 58 (62.4) 223 (82.0)
 Female 35 (37.6) 49 (18.0)
Race and ethnicity <0.001
 Non-Hispanic white 13 (14.0) 156 (57.6)
 Non-Hispanic black 72 (77.4) 79 (29.2)
 Hispanic 7 (7.9) 36 (13.4)
 Other 8 (8.6) 36 (13.4)
Age (years) 44.2 48.7 0.003
Country of birth 0.910
 United States 82 (88.2) 241 (88.6)
 Out of the United States 11 (11.8) 31 (11.4)
Married/Partnered 23 (24.5) 107 (39.2) 0.010
Public insurance 70 (76.9) 119 (43.8) <0.001
Years since HIV diagnosis 15.2 15.7 0.748
Some college education or greater 32 (34.0) 153 (56.3) <0.001
Employed for wages 38 (40.1) 171 (62.6) 0.002
History of mental illness diagnosis 51 (54.3) 93 (33.8) <0.001
 Anxiety 31 (33.0) 47 (17.1) 0.001
 Depression 39 (41.5) 66 (24.0) 0.001
 Other diagnosis 11 (11.7) 25 (9.1) 0.461
New HIV diagnosis (<3 years) 7 (7.8) 36 (13.6) 0.142
Self-reported detectable viral load 27 (28.7) 27 (9.8) <0.001
Number of daily HIV pills 2.5 (1,5) 2 (1,3)1.5 0.002
Self-reported adherence 79.5 (27.3) 95.3 (12.7) <0.001

Data displayed as N(%), mean (standard deviation), or median (interquartile range).